A comprehensive view of F. Hoffmann-La Roche Ltd. (Roche). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer Wellness Market Intelligence Service.
Roche advocates digital health solutions to address 15 million healthcare worker shortage by 2030; company emphasizes early cancer detection in oncological care
Published:
September 16, 2024
by Industry Intelligence Inc.
|
FDA approves OCREVUS ZUNOVO as first twice-yearly 10-minute subcutaneous injection for MS; treatment expands options for centers without IV infrastructure, backed by decade of Ocrevus IV safety data
Published:
September 16, 2024
by F. Hoffmann-La Roche Ltd. (Roche)
|
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "LIVER TUMOR DETECTION IN CT SCANS"
Published:
September 16, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, ROCHE DIABETES CARE GMBH, ROCHE DIABETES CARE, INC. FILES APPLICATION FOR "METHODS AND DEVICES FOR PROVIDING BLACKLIST INFORMATION ON THE SUITABILITY OF A MOBILE DEVICE FOR PERFORMING ANALYTICAL MEASUREMENTS"
Published:
September 16, 2024
by U.S. Fed News
|
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "COMBINATION THERAPY OF AN ANTI-EGFRVIII/ANTI-CD3 ANTIBODY AND AN TUMOR-TARGETED 4-1BB AGONIST"
Published:
September 16, 2024
by U.S. Fed News
|
Ask us about our Consumer Wellness market view